{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:28:37Z","timestamp":1768519717716,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105 - 2923 - B - 404 - 001 - MY3"],"award-info":[{"award-number":["MOST 105 - 2923 - B - 404 - 001 - MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["16-54-52043"],"award-info":[{"award-number":["16-54-52043"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.meegid.2018.12.031","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T17:01:20Z","timestamp":1545843680000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan"],"prefix":"10.1016","volume":"72","author":[{"given":"Ruwen","family":"Jou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena V.","family":"Kulagina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Yun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra I.","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga V.","family":"Antonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liaisan R.","family":"Arslanbaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Yuan","family":"Tasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena Yu","family":"Nosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-0904","authenticated-orcid":false,"given":"Danila V.","family":"Zimenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2018.12.031_bb0005","series-title":"Novel Gyrase Mutations in Quinolone-Resistant and -Hypersusceptible Clinical Isolates of Mycobacterium tuberculosis: Functional Analysis of Mutant Enzymes","first-page":"104","volume":"vol. 50","author":"Aubry","year":"2006"},{"key":"10.1016\/j.meegid.2018.12.031_bb0010","article-title":"Treatment outcomes of patients with multidrug-resistant and extensively drug","author":"Bastos","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2016.06.002","article-title":"Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis","author":"Brossier","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.meegid.2018.12.031_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/mmi.13890","article-title":"Regulatory genes coordinating antibiotic-induced changes in promoter activity and early transcriptional termination of the mycobacterial intrinsic resistance gene whiB7","volume":"107","author":"Burian","year":"2018","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0025","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1183\/09031936.00094708","article-title":"Extensively drug-resistant tuberculosis: is its definition correct?","volume":"32","author":"Caminero","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.meegid.2018.12.031_bb0030","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1128\/AAC.01550-10","article-title":"Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis","volume":"55","author":"Campbell","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.12.031_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciu572","article-title":"Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis","author":"Cegielski","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0045","article-title":"Population-based drug resistance surveillance of multidrug-resistant tuberculosis in Taiwan, 2007-2014","author":"Chuang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2018.12.031_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30104-X","article-title":"Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible?","author":"Cox","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0055","doi-asserted-by":"crossref","unstructured":"Dheda, K., Limberis, J.D., Pietersen, E., Phelan, J., Esmail, A., Lesosky, M., Fennelly, K.P., te Riele, J., Mastrapa, B., Streicher, E.M., Dolby, T., Abdallah, A.M., Ben-Rached, F., Simpson, J., Smith, L., Gumbo, T., van Helden, P., Sirgel, F.A., McNerney, R., Theron, G., Pain, A., Clark, T.G., Warren, R.M., 2017. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Respir. Med. https:\/\/doi.org\/10.1016\/S2213-2600(16)30433-7.","DOI":"10.1016\/S2213-2600(16)30433-7"},{"key":"10.1016\/j.meegid.2018.12.031_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/resp.13143","article-title":"Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB?","author":"Dheda","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.meegid.2018.12.031_bb0065","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.15.0221","article-title":"Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET\/RESIST-TB consensus statement","author":"Dom\u00ednguez","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02308-2016","article-title":"World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update","author":"Falzon","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.meegid.2018.12.031_bb0075","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.14.0488","article-title":"Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates","author":"Garfein","year":"2015","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0080","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.11.0559","article-title":"Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates in Uruguay","author":"Greif","year":"2012","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijid.2015.05.014","article-title":"Xpert MTB\/RIF and GenoType MTBDRplus assays for the rapid diagnosis of bone and joint tuberculosis","volume":"36","author":"Gu","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0090","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01550-17","article-title":"What is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi-and extensively drug-resistant tuberculosis","author":"Heyckendorf","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.12.031_bb0095","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00691-14","article-title":"Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis","author":"Jamieson","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2015.01.009","article-title":"Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations","author":"Kambli","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00974-18","article-title":"Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests","author":"Kandler","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.12.031_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039754","article-title":"New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: Functional genetic analysis of gyrA and gyrB mutations","volume":"7","author":"Malik","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2018.12.031_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01599-17","article-title":"Role of disputed mutations in the rpoB gene in interpretation of automated liquid MGIT culture results for rifampin susceptibility testing of Mycobacterium tuberculosis","author":"Miotto","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.05638-11","article-title":"Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis","author":"Mitarai","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0125","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1128\/JCM.02001-12","article-title":"Russian \u2018Successful\u2019 clone B0\/W148 of Mycobacterium tuberculosis Beijing genotype: a multiplex PCR assay for rapid detection and global screening","volume":"50","author":"Mokrousov","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01551-17","article-title":"A rapid assay for detection of the epidemiologically important Central Asian\/Russian strain of the Mycobacterium tuberculosis Beijing genotype","author":"Mokrousov","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0135","doi-asserted-by":"crossref","DOI":"10.1089\/mdr.2008.0798","article-title":"Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective","author":"Perdigao","year":"2008","journal-title":"Microb. Drug Resist."},{"key":"10.1016\/j.meegid.2018.12.031_bb0140","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1128\/AAC.02191-12","article-title":"Aminoglycoside cross-resistance in Mycobacterium tuberculosis due to mutations in the 5\u2032 untranslated region of whiB7","volume":"57","author":"Reeves","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.12.031_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.01947","article-title":"Correlation of rpoB mutations with minimal inhibitory concentration of rifampin and rifabutin in Mycobacterium tuberculosis in an HIV\/AIDS endemic setting, South Africa","author":"Rukasha","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0150","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1128\/JCM.05195-11","article-title":"Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis","volume":"49","author":"Sharma","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2018.12.031_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2014.04.006","article-title":"Facing multi-drug resistant tuberculosis","author":"Sotgiu","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.meegid.2018.12.031_bb0160","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01357-08","article-title":"Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis","author":"Starks","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.12.031_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2015.42","article-title":"Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates","author":"Torres","year":"2015","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.meegid.2018.12.031_bb0170","doi-asserted-by":"crossref","DOI":"10.5588\/ijtld.10.0127","article-title":"Low-level rifampicin-resistant Mycobacterium tuberculosis strains raise a new therapeutic challenge","author":"Van Ingen","year":"2011","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0175","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","author":"Vilch\u00e8ze","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.meegid.2018.12.031_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1473-3099(13)70025-2","article-title":"Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action","volume":"13","author":"Wells","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2018.12.031_bb0185","series-title":"Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs","author":"WHO","year":"2008"},{"key":"10.1016\/j.meegid.2018.12.031_bb0190","series-title":"WHO Global Tuberculosis Report 2017","author":"WHO","year":"2017"},{"key":"10.1016\/j.meegid.2018.12.031_bb0195","series-title":"Rapid Communication: Key Changes to Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis (MDR\/RR-TB)","author":"WHO","year":"2018"},{"key":"10.1016\/j.meegid.2018.12.031_bb0200","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201305-0926OE","article-title":"Tuberculosis in Russia: its history and its status today","author":"Yablonskii","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.meegid.2018.12.031_bb0205","doi-asserted-by":"crossref","first-page":"20004","DOI":"10.1073\/pnas.0907925106","article-title":"Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis","volume":"106","author":"Zaunbrecher","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2018.12.031_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2012.18","article-title":"\u2018ZS-MDR-TB\u2019 versus \u2018ZR-MDR-TB\u2019: improving treatment of MDR-TB by identifying pyrazinamide susceptibility","author":"Zhang","year":"2012","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.meegid.2018.12.031_bb0215","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/jac\/dkw015","article-title":"Simultaneous drug resistance detection and genotyping of Mycobacterium tuberculosis using a low-density hydrogel microarray","volume":"71","author":"Zimenkov","year":"2016","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818309705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818309705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T03:13:44Z","timestamp":1662693224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134818309705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":42,"alternative-id":["S1567134818309705"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2018.12.031","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2018.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}